Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Lazertinib vs Gefitinib in Treatment-Naive Patients with EGFR-mutated NSCLC: LASER301 Asian Subpopulation Analysis
- Authors
- Reungwetwattana, T.; Cho, B. C.; Lee, K. H.; Pang, Y. K.; Fong, C. H.; Kang, J. H.; Lee, Y. -G.; Lim, C. S.; Danchaivijitr, P.; Lim, Y. N.; Lee, Y.; How, S. H.; Geater, S.; Lee, S. S.; Min, Y. J.; Kim, J. -H.; Lee, J. -S.; Lee, G. -W.; Soo, R. A.; Choi, S.; Lee, S. Y.; Ahn, M. -J.
- Issue Date
- Nov-2023
- Publisher
- Elsevier Inc.
- Keywords
- lazertinib; EGFR; NSCLC
- Citation
- Journal of Thoracic Oncology, v.18, no.11, pp S331 - S331
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Thoracic Oncology
- Volume
- 18
- Number
- 11
- Start Page
- S331
- End Page
- S331
- ISSN
- 1556-0864
1556-1380
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.